CDRH’s Mansfield Addresses Upcoming Drug/Dx Co-Development Guidance

Either an IND or an IDE will be sufficient for companion diagnostic studies, a CDRH diagnostics official clarified last week. That is among the issues that will be addressed in an upcoming co-development draft guidance.

More from Regulation

More from Policy & Regulation